Top Markets
#1 Geodnet Geodnet +18.34%
#2 Neiro Neiro +18.17%
#3 XPIN Network XPIN Network +16.90%
#4 Derive Derive +15.52%
#5 Mubarak Mubarak +15.11%
#6 Pons Pons +14.48%
#7 Status Status +13.42%
#8 Collect on Fanable Collect on Fanable +13.26%
#9 ETHGas ETHGas +12.81%
#10 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +11.99%
Coin of the day
Geodnet Geodnet
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Cortexyme, Inc. Cortexyme, Inc.

Cortexyme, Inc.

CRTX
Rang in Aktien #25183
Cortexyme, Inc. is a clinical-stage biopharmaceutical firm committed to... Cortexyme, Inc. is a clinical-stage biopharmaceutical firm committed to pioneering new therapies for Alzheimer's and various other degenerative conditions. The company's primary investigational drug, atuzaginstat (also known as COR388), is an orally delivered, small molecule inhibitor engineered to cross the blood-brain barrier and target gingipain. This compound is currently in Phase II/III clinical trials, where it is being assessed for its potential use in individuals with mild to moderate Alzheimer's disease, as well as for tackling oral squamous cell carcinoma, periodontitis, and coronavirus infections. Established in 2012, Cortexyme, Inc. is headquartered in South San Francisco, California.
Aktienkurs
$1.95
Zuletzt synchronisiert: 2022-07-29
Marktkapitalisierung
$52.48M
Veränderung (1 Tag)
2.63%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Cortexyme, Inc. (CRTX)

Kategorie

Healthcare
Kursverlauf für Cortexyme, Inc. (CRTX)
Höchster Schlusskurs: $2.18 am 2022-07-01

Niedrigster Schlusskurs: $26.37 am 2019-05-01
Kursverlauf der Aktie von Cortexyme, Inc. von 2019 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2022 -82.87%
2021 -62.60%
2020 -23.16%
2019 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $539.14 35.65%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 56.21%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -18.24%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $761.87 8.65%
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $130.43 397.46%
US